Laobaixing Pharmacy Total Liabilities
Laobaixing Pharmacy total liabilities. Based on the latest financial reports, Laobaixing Pharmacy (603883) has total liabilities worth CN¥12.61 Billion CNY (≈ $1.85 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Laobaixing Pharmacy's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Laobaixing Pharmacy (2011–2025)
Total liabilities of Laobaixing Pharmacy from 2011 to 2025. This chart illustrates how Laobaixing Pharmacy's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Laobaixing Pharmacy's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Laobaixing Pharmacy Competitors by Total Liabilities
The table below lists competitors of Laobaixing Pharmacy ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Robertet SA
PA:RBT
|
France | €399.53 Million |
|
Husqvarna AB (publ)
ST:HUSQ-B
|
Sweden | Skr32.90 Billion |
|
Lindblad Expeditions Holdings Inc
NASDAQ:LIND
|
USA | $1.20 Billion |
|
ASBISc Enterprises PLC
WAR:ASB
|
Poland | zł928.10 Million |
|
Apollo Micro Systems Limited
NSE:APOLLO
|
India | Rs-13.08 Billion |
|
Telkom
JSE:TKG
|
South Africa | ZAC28.53 Billion |
|
Sarda Energy & Minerals Limited
NSE:SARDAEN
|
India | Rs38.94 Billion |
|
PC Jeweller Limited
NSE:PCJEWELLER
|
India | Rs12.51 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Laobaixing Pharmacy's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603883 total assets.
Liquidity & Leverage Metrics
Laobaixing Pharmacy Total Liabilities Ratios Explained
Laobaixing Pharmacy total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laobaixing Pharmacy's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laobaixing Pharmacy (2011–2025)
The table below shows the annual total liabilities of Laobaixing Pharmacy from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥12.85 Billion ≈ $1.88 Billion |
-14.27% |
| 2024-12-31 | CN¥14.99 Billion ≈ $2.19 Billion |
+7.51% |
| 2023-12-31 | CN¥13.94 Billion ≈ $2.04 Billion |
-2.50% |
| 2022-12-31 | CN¥14.30 Billion ≈ $2.09 Billion |
+17.41% |
| 2021-12-31 | CN¥12.18 Billion ≈ $1.78 Billion |
+87.99% |
| 2020-12-31 | CN¥6.48 Billion ≈ $948.04 Million |
+7.09% |
| 2019-12-31 | CN¥6.05 Billion ≈ $885.24 Million |
+18.26% |
| 2018-12-31 | CN¥5.12 Billion ≈ $748.55 Million |
+42.18% |
| 2017-12-31 | CN¥3.60 Billion ≈ $526.47 Million |
+21.37% |
| 2016-12-31 | CN¥2.96 Billion ≈ $433.78 Million |
+96.50% |
| 2015-12-31 | CN¥1.51 Billion ≈ $220.75 Million |
+4.47% |
| 2014-12-31 | CN¥1.44 Billion ≈ $211.31 Million |
+14.31% |
| 2013-12-31 | CN¥1.26 Billion ≈ $184.85 Million |
+43.11% |
| 2012-12-31 | CN¥882.72 Million ≈ $129.17 Million |
-3.30% |
| 2011-12-31 | CN¥912.83 Million ≈ $133.58 Million |
-- |
About Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more